Radiotherapy for tumours of the eye;Radiotherapie des tumeurs intraoculaires

Cancer/Radiotherapie

Volumn 3, Issue SUPPL. 1, 1999, Pages 102-106

  Sauerwein, W ^a   Gerard J P ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Iodine 125; Ocular tumours; Proton therapy; Ruthenium 106

Indexed keywords

IODINE 125; RUTHENIUM 106;

BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CHOROID CANCER; CONFERENCE PAPER; EYE TUMOR; FRANCE; HUMAN; IRRADIATION; METASTASIS; PHOTOTHERAPY; PRIORITY JOURNAL; RETINOBLASTOMA; UVEA MELANOMA;

EID: 0344577918     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. 125I ophthalmic plaque brachytherapy. Med Phys 1990 ; 17 : 1053-7.
2. Bornfeld N, Chauvel P, Sauerwein W, Friedrichs W, Tiburtius T, Wessing A, et al. Metastatic disease, eye retention and visual function in conservative treatment of uveal melanoma. Front Radiat Ther Oncol 1997 ; 30 : 97-110.
3. Bornfeld N, Sauerwein W, Kellner U, Foerster MH, Chauvel P, Schreiber J, et al. Juxtapapillary melanomas of the choroid: results and limitations of eye salvaging treatment modalities. Annual Brachytherapy Meeting GEC-ESTRO, Venezia, May 12-14, 1993. Programme and abstracts, p. 181.
4. Bühner A. Spätfolgen der Strahlentherapie beim unilateralen Retinoblastom. Inauguraldissertation zur erlangung des Doktorgrades der Medizin durch die Medizinische Fakultät der Universität GH Essen, 1997.
5. Busch M, Sauerwein W. Klinisch-methodische Grundlagen der Brachytherapie. In: Scherer E, Sack H, eds. Strahlentherapie -Radiologische Onkologie, 4. Auflage. Springer-Verlag: Berlin; 1996. p. 81-108.
6. 125I brachytherapy versus helium ion irradiation. Ophthalmology 1989 ; 96 : 1708-15.
7. Char DH, Quivey JM, Castro JR, Kroll S, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 1993 ; 100 : 1547-54.
8. Chauvel P, Sauerwein W, Bornfeld N, Friedrichs W, Brassart N, Courdi A, et al., and participants of the SERAG (South Europe Radiotherapy Group). Clinical and technical requirements for proton treatment planning of ocular disease. Front Radiat Ther Oncol 1997 ; 30 : 133-42.
9. Earle J, Kline RW, Robertson DM. Selection of iodine 125 for the Collaborative Ocular Melanoma Study. Arch Ophthalmol 1987 ; 6 : 763-4.
10. Egan KM, Gragoudas ES, Seddon JM, Glynn RJ, Munzenreider JE, Goitein M, et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology 1989 ; 96 : 1377-82.
11. Flühs D, Bambynek M, Heintz M, Indenkämpen F, Kolanoski H, Wegener D, et al. Dosimetry and design of radioactive eye plaques. Front Radiat Ther Oncol 1997 ; 30 : 26-38.
12. 106Rh-Augenapplikatoren. In: Müller RG, Erb J, eds. Tagungsband DGMP Medizinische Physik. Erlangen: Deutsche Gesellschaft für Medizinische Physik; 1993. p. 93.
13. Gérard JP, Sauerwein W, Sentenac I. Ophthalmic tumors: uveal melanomas. In: Pierquin B, Marinello G, eds. A Practical Manual of Brachytherapy. Madison, Wisconsin: Medical Physics Publishing; 1997. p. 253-7.
14. Glaeser L, Quast U. Dosimetry for high precision radiotherapy of the eye. Proceedings of the first European Mevatron-users conference. Erlangen: Siemens; 1987.
15. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991 ; 98 : 383-9.
16. Harnett AN, Hungerford JL, Lambert GD, Hirst A, Darlison R, Hart BL, et al. Improved external beam radiotherapy for the treatment of retinoblastoma. Br J Radiol 1987 ; 60 : 753-60.
17. Hideghéty K, Sauerwein W, Flühs D, Wening J, Chauvel P, Brassard N, et al. Proton beam irradiation of high risk parapapillary, paramaculary uveal melanomas. Radiother Oncol 1998 ; 48 (suppl. 1) : 157.
18. Karolis C, Frost RB, Billson FA. A thin I-125 seed eye plaque to treat intraocular tumors using an acrylic insert to precisely position the sources. Int J Radiat Oncol Biol Phys 1990 ; 18 : 1209-13.
19. Linstadt D, Castro J, Char D, Decker M, Ahn D, Petti P, Nowakowski V, et al. Long-term results of helium ion irradiation of uveal melanoma. Int J Radiat Oncol Biol Phys 1990 ; 19 : 613-8.
20. Lommatzsch PK. Intraokulare Tumoren. Stuttgart: Enke Verlag; 1989.
21. 106Rh) unter Erhaltung der Sehfähigkeit. Klin Monatsbl Augenheilkd 1966 ; 148 : 682-99.
22. Messmer EP, Fritze H, Mohr C, Heinrich T, Sauerwein W, Havers W, et al. Long-term treatment effects in patients with bilateral retinoblastoma: ocular and mid-facial findings. Graefes Arch Clin Exp Ophthalmol 1991 ; 229 : 309-14.
23. Messmer EP, Sauerwein W, Heinrich T, Höpping W, Klueter-Reckmann D, Bornfeld N, et al. New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefes Arch Clin Exp Ophthalmol 1990 ; 228 : 426-31.
24. Moore RF. Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol 1930 ; 14 : 145-56.
25. Packer S, Stoller S, Lesser ML, Mandel FS, Finger P. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 1992 ; 99 : 767-73.
26. Sauerwein W, Höpping W, Bornfeld N. Radiotherapy for retinoblastoma - Treatment strategies. Front Radiat Ther Oncol 1997 ; 30 : 93-6.
27. Sauerwein W, Sack H. Auge und Orbita. In: Scherer E, Sack H, eds. Strahlentherapie - Radiologische Onkologie, 4. Auflage, Springer-Verlag: Berlin; 1996. p. 425-52.
28. Schipper J. An accurate and simple method for megavoltage radiation therapy of retinoblastoma. Radiother Oncol 1983 ; 1 : 31-41.
29. Schipper J, Tan KE, van Peperzeel HA. Treatment of retinoblastoma by precision megavoltage radiation therapy. Radiother Oncol 1985 ; 3 : 117-32.
30. Sealy R, le Roux PLM, Rapely F, Hering E, Shackleton D, Sevel D. The treatment of ophthalmic tumours with low-energy sources. Br J Radiol 1976 ; 49 : 551-4.
31. Stallard, H B. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol 1966 ; 50 : 147-55.